Who owns AADI BIOSCIENCE INC COM?
- CUSIP Number: 00032q104
Tip: Access positions for across all investors
Analyze quarterly positions in Aadi Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aadi Bioscience stock
Who bought or sold AADI BIOSCIENCE INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| QVT Financial | 4.5M | $7.6M | 95% | Mar 2025 |
|
| OrbiMed Advisors | 4.2M | $7.4M | 100% | Mar 2025 |
|
| venBio Select Advisor | 2.8M | $9.0M | 0% | Dec 2024 |
|
| Siren | 2.1M | $3.7M | 100% | Mar 2025 |
|
| BML Capital Management | 1.9M | $3.4M | -10% | Mar 2025 |
|
| Longwood Capital Partners | 1.8M | $5.8M | 0% | Dec 2024 |
|
| Acorn Capital Advisors | 1.1M | $2.0M | -1% | Mar 2025 |
|
| Ally Bridge Group | 818k | $2.6M | 100% | Dec 2024 |
|
| Vanguard Group | 766k | $1.4M | 0% | Mar 2025 |
|
| Renaissance Technologies | 462k | $823k | 1% | Mar 2025 |
|
| EcoR1 Capital | 345k | $1.1M | -81% | Dec 2024 |
|
| Soleus Capital Management | 333k | $1.1M | 0% | Dec 2024 |
|
| Bridgeway Capital Management | 315k | $561k | 173% | Mar 2025 |
|
| Peapod Lane Capital | 241k | $430k | -46% | Mar 2025 |
|
| BlackRock | 241k | $429k | -1% | Mar 2025 |
|
| Geode Capital Management | 236k | $420k | 9% | Mar 2025 |
|
| Citadel Advisors | 102k | $182k | 27% | Mar 2025 |
|
| Northern Trust | 86k | $154k | -5% | Mar 2025 |
|
| State Street Corporation | 69k | $122k | 0% | Mar 2025 |
|
| Susquehanna International | 58k | $181k | -20% | Dec 2024 |
|
| Millennium Management | 45k | $80k | -74% | Mar 2025 |
|
| Two Sigma Investments | 43k | $77k | -37% | Mar 2025 |
|
| Schonfeld Strategic Advisors | 42k | $131k | 0% | Dec 2024 |
|
| Two Sigma Advisers | 41k | $73k | -34% | Mar 2025 |
|
| SG Americas Securities | 37k | $65k | 100% | Mar 2025 |
|
| Dimensional Fund Advisors | 36k | $112k | 0% | Dec 2024 |
|
| UBS Group | 36k | $63k | -40% | Mar 2025 |
|
| ABG Innovation Capital Partners III GP | 27k | $84k | 0% | Dec 2024 |
|
| Jane Street | 27k | $48k | 100% | Mar 2025 |
|
| Prudential Financial | 26k | $83k | 0% | Dec 2024 |
|
| Man Group | 15k | $46k | 0% | Dec 2024 |
|
| Morgan Stanley | 13k | $40k | 100% | Dec 2024 |
|
| Springbok Capital Management | 10k | $18k | -21% | Mar 2025 |
|
| Us Bancorp | 3.3k | $5.9k | 0% | Mar 2025 |
|
| Advisor Group Holdings | 3.1k | $5.5k | 4% | Mar 2025 |
|
| Jpmorgan Chase & Co | 1.8k | $3.1k | 19% | Mar 2025 |
|
| Russell Investments | 1.5k | $4.8k | 0% | Dec 2024 |
|
| Bartlett & Co. Wealth Management | 1.3k | $2.4k | 0% | Mar 2025 |
|
| Federated Investors | 930.00 | $1.7k | -80% | Mar 2025 |
|
| Satter Management | 659.00 | $2.1k | 0% | Dec 2024 |
|
| Group One Trading | 500.00 | $1.6k | 100% | Dec 2024 |
|
| Tower Research Capital | 414.00 | $1.3k | -77% | Dec 2024 |
|
| Semmax Financial Advisors | 297.00 | $145k | 100% | Mar 2025 |
|
| TD Waterhouse Canada | 232.00 | $394.005600 | 0% | Mar 2025 |
|
| Bank of America Corporation | 172.00 | $543.004000 | -19% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 160.00 | $284.992000 | -19% | Mar 2025 |
|
| Citigroup | 75.00 | $134.002500 | 0% | Mar 2025 |
|
| Wells Fargo & Company | 33.00 | $59.000700 | -94% | Mar 2025 |
|
| CWM | 25.00 | $0 | 0% | Mar 2025 |
|
| SBI Securities | 20.00 | $36.000000 | -95% | Mar 2025 |
|
| Parallel Advisors | 8.00 | $14.000000 | 0% | Mar 2025 |
|
Who sold out of Aadi Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marquette Asset Management | Dec 2024 | 64k | $201k |
| Affinity Asset Advisors | Sep 2024 | 47k | $97k |
| Royal Bank of Canada | Dec 2024 | 40k | $126k |
| XTX Topco | Dec 2024 | 13k | $42k |
| Point72 Asia | Dec 2024 | 12k | $37k |
| Squarepoint Ops | Sep 2024 | 11k | $22k |
| Cubist Systematic Strategies | Dec 2024 | 6.6k | $21k |
| Simplex Trading | Dec 2024 | 558.00 | $999.991800 |
| Point72 | Dec 2024 | 77.00 | $242.996600 |